Evaluation of risk of glucose fluctuation during nighttime by Average Daily Risk Range (ADRR) in type 1 diabetes

Evaluation of risk of glucose fluctuation during nighttime by Average Daily Risk Range (ADRR) in type 1 diabetes - Evaluation of risk of glucose fluctuation during nighttime by ADRR in type 1 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021172

Enrollment

Registered

2016-02-25

Start date

2016-03-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age 20 and ove, below 80 at consent 2) Type 1 diabetes 3) Patients who can do SMBG three times a day 4) Provided written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with liver cirrhosis and renal failure (hemodialysis and serum creatinine 2.0mg/dl and over) 2) Pregnant patients 3) Malignancy 4) Considered inadequate by the investigator

Design outcomes

Primary

Measure	Time frame
Correlations between frequencies of hypoglycemia (below 70mg/dl), hyperglycemia (200mg/dl and over) and mean blood glucose during nighttime (0:00-5:59) and ADRR	—

Secondary

Measure	Time frame
Correlations between frequencies of hypoglycemia (below 70mg/dl), hyperglycemia (200mg/dl and over) and mean blood glucose during daytime (6:00-23:59) and ADRR	—

Countries

Japan

Contacts

Public ContactAkio Kanazawa

Juntendo University Graduate School of Medicine Department of Metabolism & Endocrinology

akana@juntendo.ac.jp03-3813-3111

Outcome results